Use of proton pump inhibitors and risk of pancreatic adenocarcinoma: A case-control study based on the French national health data system (SNDS)

被引：0
|
作者：
Lassalle, Marion [1 ,2 ]
Le Tri, Thien [1 ,2 ]
Afchain, Pauline [3 ]
Camus-Duboc, Marine [4 ]
Kirchgesner, Julien [5 ]
Zureik, Mahmoud [6 ]
Dray-Spira, Rosemary [1 ,2 ]
机构：
[1] French Natl Agcy Safety Med & Hlth Prod ANSM, EPI PHARE Epidemiol Hlth Prod, St Denis, France
[2] French Natl Hlth Insurance CNAM, St Denis, France
[3] Hop St Antoine, AP HP, Dept Med Oncol, Paris, France
[4] Sorbonne Univ, Ctr Rech St Antoine, UMRS 938, Paris, France
[5] Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France
[6] French Natl Agcy Safety Med & Hlth Prod & French, EPI PHARE, Epidemiol Hlth Prod, St Denis, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：14 / 15
页数：2
相关论文
共 50 条
  • [1] Use of Proton Pump Inhibitors and Risk of Pancreatic Cancer: A Nationwide Case-Control Study Based on the French National Health Data System (SNDS)
    Lassalle, Marion
    Thien Le Tri
    Afchain, Pauline
    Camus, Marine
    Kirchgesner, Julien
    Zureik, Mahmoud
    Dray-Spira, Rosemary
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (03) : 662 - 669
  • [2] Use of Proton Pump Inhibitors Correlates with Increased Risk of Pancreatic Cancer: A Case-Control Study in Taiwan
    Lai, Shih-Wei
    Sung, Fung-Chang
    Lin, Cheng-Li
    Liao, Kuan-Fu
    KUWAIT MEDICAL JOURNAL, 2014, 46 (01): : 44 - 48
  • [3] Use of Proton Pump Inhibitors and the Risk of Listeriosis: A Nationwide Registry-based Case-Control Study
    Jensen, Anne Kvistholm
    Simonsen, Jacob
    Ethelberg, Steen
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (07) : 845 - 851
  • [4] Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study
    Tran-Duy, A.
    Connell, N. J.
    Vanmolkot, F. H.
    Souverein, P. C.
    de Wit, N. J.
    Stehouwer, C. D. A.
    Hoes, A. W.
    de Vries, F.
    de Boer, A.
    JOURNAL OF INTERNAL MEDICINE, 2019, 285 (02) : 205 - 214
  • [5] Proton pump inhibitors and risk of gastric cancer in a case-control study
    Lai, Shih-Wei
    Lai, Hsueh-Chou
    Lin, Cheng-Li
    Liao, Kuan-Fu
    GUT, 2019, 68 (04) : 765 - 767
  • [6] Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case-Control Study
    Peng, Yen-Chun
    Lin, Cheng-Li
    Hsu, Wan-Yun
    Lu, I-Ta
    Yeh, Hong-Zen
    Chang, Chi-Sen
    Kao, Chia-Hung
    DOSE-RESPONSE, 2018, 16 (04):
  • [7] Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
    Pouwels, S.
    Lalmohamed, A.
    Souverein, P.
    Cooper, C.
    Veldt, B. J.
    Leufkens, H. G.
    de Boer, A.
    van Staa, T.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 903 - 910
  • [8] Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
    S. Pouwels
    A. Lalmohamed
    P. Souverein
    C. Cooper
    B. J. Veldt
    H. G. Leufkens
    A. de Boer
    T. van Staa
    F. de Vries
    Osteoporosis International, 2011, 22 : 903 - 910
  • [9] Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study
    Chiu, Hui-Fen
    Huang, Ya-Wen
    Chang, Chih-Ching
    Yang, Chun-Yuh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (11) : 1131 - 1136
  • [10] Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study
    Chuang, Shih-Chieh
    Lin, Che-Chen
    Peng, Cheng-Yuan
    Huang, Wen-Hsin
    Su, Wen-Pang
    Lai, Shih-Wei
    Lai, Hsueh-Chou
    GUT, 2019, 68 (07) : 1337 - +
12345